For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Caris Life Sciences Inc (NASDAQ: CAI) closed at $28.24 up 0.86% from its previous closing price of $28.0. In other words, the price has increased by $0.86 from its previous closing price. On the day, 0.55 million shares were traded. CAI stock price reached its highest trading level at $28.46 during the session, while it also had its lowest trading level at $28.03.
Ratios:
For a deeper understanding of Caris Life Sciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.36 and its Current Ratio is at 9.93. In the meantime, Its Debt-to-Equity ratio is 0.89 whereas as Long-Term Debt/Eq ratio is at 0.88.
Upgrades & Downgrades
In the most recent recommendation for this company, Canaccord Genuity on December 02, 2025, initiated with a Hold rating and assigned the stock a target price of $28.
On July 14, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $32.
On July 14, 2025, TD Cowen started tracking the stock assigning a Buy rating and target price of $32.TD Cowen initiated its Buy rating on July 14, 2025, with a $32 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 11 ’25 when Power Luke Thomas sold 62,250 shares for $26.58 per share. The transaction valued at 1,654,461 led to the insider holds 99,571 shares of the business.
LUKE POWER bought 62,250 shares of CAI for $1,686,975 on Dec 11 ’25. On Nov 07 ’25, another insider, Denton John Russel, who serves as the insider of the company, bought 4,184 shares for $24.09 each. As a result, the insider paid 100,793 and bolstered with 9,184 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAI now has a Market Capitalization of 7967828480 and an Enterprise Value of 7639074304. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.28 while its Price-to-Book (P/B) ratio in mrq is 16.65. Its current Enterprise Value per Revenue stands at 11.769 whereas that against EBITDA is -144.259.
Stock Price History:
Over the past 52 weeks, CAI has reached a high of $42.50, while it has fallen to a 52-week low of $22.86. The 50-Day Moving Average of the stock is 2.28%, while the 200-Day Moving Average is calculated to be -5.59%.
Shares Statistics:
For the past three months, CAI has traded an average of 1.63M shares per day and 2065710 over the past ten days. A total of 282.10M shares are outstanding, with a floating share count of 115.32M. Insiders hold about 59.13% of the company’s shares, while institutions hold 37.37% stake in the company. Shares short for CAI as of 1765756800 were 5434034 with a Short Ratio of 3.33, compared to 1763078400 on 5146467. Therefore, it implies a Short% of Shares Outstanding of 5434034 and a Short% of Float of 3.73.
Earnings Estimates
The company has 3 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.66 and -$0.73 for the fiscal current year, implying an average EPS of -$0.69. EPS for the following year is $0.19, with 4.0 analysts recommending between $0.46 and -$0.05.
Revenue Estimates
For the next quarter, 8 analysts are estimating revenue of $204.64M. There is a high estimate of $214M for the next quarter, whereas the lowest estimate is $200.7M. Based on 9 analysts’ estimates, the company’s revenue will be $976.03M in the next fiscal year. The high estimate is $1.02B and the low estimate is $932.2M.
